Paul Klotman

Q: What Schools Are Affiliated With Paul Klotman

Paul Klotman is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, University of Virginia, Duke University, Tulane University

Paul Klotman's AcademicInfluence.com Rankings

Paul Klotman

Philosophy

#10420

World Rank

#14277

Historical Rank

Logic

#7292

World Rank

#9008

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul Klotman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul E. Klotman is an American physician-scientist and academic administrator. He is the president, CEO and executive dean of the Baylor College of Medicine, a position he began on Sept. 1, 2010. He is the fifth person to serve as president of the College, located in Houston in the Texas Medical Center, which operates as a health sciences university with four schools: Medical School, Graduate School of Biomedical Sciences, School of Health Professions and National School of Tropical Medicine. Klotman joined Baylor at a time when it was experiencing great financial difficulties, and led a successful turnaround.

(See a Problem?)

Paul Klotman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. (2005) (639)
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. (1996) (449)
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. (2004) (354)
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. (2001) (322)
Renal epithelium is a previously unrecognized site of HIV-1 infection. (2000) (308)
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy (2002) (299)
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. (1992) (290)
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. (1993) (234)
Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. (1997) (233)
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans (2012) (215)
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. (2005) (201)
Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality (2006) (190)
Cellular and molecular mechanisms of cyclosporin nephrotoxicity. (1990) (185)
HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. (1999) (183)
HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. (2000) (180)
Chronic kidney disease in HIV infection: an urban epidemic (2007) (177)
EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY (1987) (172)
Recent progress in HIV-associated nephropathy. (2002) (168)
Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. (2004) (167)
Cardiac Dysfunction Occurs in the HIV-1 Transgenic Mouse Treated with Zidovudine (2000) (146)
HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. (2002) (142)
HIV-associated nephropathy. (1998) (135)
Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. (1995) (133)
Identification and characterization of a cell membrane nucleic acid channel. (1998) (126)
HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. (2008) (125)
The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. (2009) (125)
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. (2011) (118)
Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors. (1994) (118)
Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. (1991) (112)
Are we missing an epidemic of HIV-associated nephropathy? (1996) (107)
Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. (1992) (105)
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis (2008) (104)
HIV-1 Nef Disrupts the Podocyte Actin Cytoskeleton by Interacting with Diaphanous Interacting Protein* (2008) (100)
Prospective Analysis of Strategies for Diagnosing Renovascular Hypertension (1989) (99)
Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys. (2002) (95)
Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. (2004) (91)
Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. (1987) (89)
Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. (2007) (89)
Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. (2006) (88)
HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN (2005) (88)
bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. (1994) (88)
The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. (1998) (87)
Krüppel-like Factor 15 (KLF15) Is a Key Regulator of Podocyte Differentiation* (2012) (84)
HIV-1 Infection Initiates an Inflammatory Cascade in Human Renal Tubular Epithelial Cells (2006) (84)
Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. (2001) (83)
HIV-associated nephropathy: Epidemiology, pathogenesis, and treatment. (2003) (82)
Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells. (2011) (80)
Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction (2010) (79)
Functional role of thromboxane production by acutely rejecting renal allografts in rats. (1985) (78)
Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. (2009) (74)
Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. (2001) (74)
HIV-associated nephropathy (1999) (74)
Epidermal growth factor (EGF) expression in the congenital polycystic mouse kidney. (1991) (72)
HIV-associated nephropathy: pathogenesis (2011) (71)
HIV-1 upregulates VEGF in podocytes. (2008) (69)
Microalbuminuria Is Associated With All-Cause and AIDS Mortality in Women With HIV Infection (2010) (68)
Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. (1996) (67)
Reduction of Stat3 activity attenuates HIV-induced kidney injury. (2009) (66)
Renal safety of tenofovir disoproxil fumarate. (2007) (66)
Critical role for Nef in HIV-1-induced podocyte dedifferentiation. (2003) (65)
Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. (1993) (64)
Chronic rejection of mouse kidney allografts. (1999) (63)
Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. (1999) (63)
Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells. (1999) (62)
Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. (2000) (62)
Thromboxane stimulates synthesis of extracellular matrix proteins in vitro. (1991) (61)
Podocan, a Novel Small Leucine-rich Repeat Protein Expressed in the Sclerotic Glomerular Lesion of Experimental HIV-associated Nephropathy* (2003) (61)
HIV-associated nephropathy in the era of antiretroviral therapy. (2007) (59)
Role of the retinoic acid receptor-α in HIV-associated nephropathy. (2011) (59)
Renal vein renins: inability to predict response to revascularization in patients with hypertension. (1991) (58)
Transgenic and infectious animal models of HIV-associated nephropathy. (2009) (58)
Renal TGF-β in HIV-associated kidney diseases (1997) (57)
Lentiviral gene transduction of kidney. (2002) (56)
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells (2010) (55)
Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. (1990) (54)
Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. (1986) (54)
Estimating Kidney Function in HIV-Infected Adults in Kenya: Comparison to a Direct Measure of Glomerular Filtration Rate by Iohexol Clearance (2013) (54)
HIV-associated nephropathy: an urban epidemic. (2001) (52)
Career development of physician scientists: a survey of leaders in academic medicine. (2011) (52)
Expression of HIV transgene aggravates kidney injury in diabetic mice (2013) (51)
Urinary NGAL marks cystic disease in HIV-associated nephropathy. (2009) (49)
Water deprivation stimulates transforming growth factor-beta 2 accumulation in the juxtaglomerular apparatus of mouse kidney. (1991) (49)
Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. (1994) (48)
HIV-associated nephropathy: case study and review of the literature. (2000) (48)
The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. (1989) (47)
Intravenous digital subtraction renal angiography: use in screening for renovascular hypertension. (1989) (47)
Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase. (2013) (47)
Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. (2015) (46)
Thromboxane and prostacyclin differentially regulate murine extracellular matrix gene expression. (1993) (46)
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes. (2001) (45)
FAT10: a Novel Mediator of Vpr-Induced Apoptosis in Human Immunodeficiency Virus-Associated Nephropathy (2009) (45)
Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. (1994) (45)
Recent progress in HIV-associated nephropathy. (2012) (44)
HIV-1 and HIV-Associated Nephropathy 25 Years Later. (2007) (44)
Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected Podocytes (2008) (43)
Cutaneous disorders and viral gene expression in HIV-1 transgenic mice. (1993) (43)
Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice. (1994) (43)
Treatment of HIV-associated nephropathy. (2000) (43)
Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. (1992) (43)
Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy. (1994) (42)
Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection (2006) (42)
HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. (2008) (42)
Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury. (2014) (41)
Transgenic models of human immunodeficiency virus type-1. (1996) (40)
Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy (2013) (40)
Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. (1989) (40)
Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system. (1979) (38)
Up-regulation of the Homophilic Adhesion Molecule Sidekick-1 in Podocytes Contributes to Glomerulosclerosis* (2010) (38)
Similar Prevalence of Renovascular Hypertension in Selected Blacks and Whites (1991) (37)
Pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. (1998) (36)
Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. (2004) (36)
Cytosolic malate dehydrogenase confers selectivity of the nucleic acid-conducting channel (2002) (36)
World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease. (2009) (36)
Effect of Tissue Processing on the Ability to Recover Nucleic Acid from Specific Renal Tissue Compartments by Laser Capture Microdissection (2001) (34)
EVIDENCE THAT PRETRANSPLANT DONOR BLOOD TRANSFUSION PREVENTS RAT RENAL ALLOGRAFT DYSFUNCTION BUT NOT THE IN SITU CELLULAR ALLOIMMUNE OR MORPHOLOGIC MANIFESTATIONS OF REJECTION12 (1988) (34)
Transgenic models of HIV-1. (1995) (34)
Increased Expression of α4β1 and α5β1 Integrins on HTLV-I-Infected Lymphocytes (1993) (34)
Patterns of HIV-1 mRNA expression in transgenic mice are tissue-dependent. (1994) (34)
HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. (1993) (34)
Animal models of HIV-associated nephropathy (2006) (32)
Reduction of renal blood flow and proximal bicarbonate reabsorption in rats by gentamicin. (1983) (32)
The homophilic adhesion molecule sidekick‐1 contributes to augmented podocyte aggregation in HIV‐associated nephropathy (2007) (31)
HIV-associated nephropathy. (2004) (30)
Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats. (1990) (30)
HIV-1 infection of human T lymphocytes results in enhanced alpha 5 beta 1 integrin expression (1991) (29)
Renal vascular induction of TGF-β2 and renin by potassium depletion (1993) (29)
Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. (2009) (29)
Update on HIV-associated nephropathy (2006) (28)
Detection and localization of HIV-1 DNA in renal tissues by in situ polymerase chain reaction. (2006) (28)
Molecular therapy for renal diseases. (1996) (27)
Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension. (1988) (27)
Podocytes in HIV-Associated Nephropathy (2007) (27)
Pre-Existing Albuminuria Predicts Aids and Non-Aids Mortality in Women Initiating Antiretroviral Therapy (2011) (26)
Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy. (2013) (25)
Clinical Characteristics Useful in Screening for Renovascular Disease (1990) (25)
Captopril renography in the diagnosis of renovascular disease. (1991) (24)
In vivo gene transfer to kidney by lentiviral vector. (2002) (22)
Definition of the critical domains required for homophilic targeting of mouse sidekick molecules (2005) (22)
Novel Small Leucine-Rich Repeat Protein Podocan Is a Negative Regulator of Migration and Proliferation of Smooth Muscle Cells, Modulates Neointima Formation, and Is Expressed in Human Atheroma (2013) (22)
Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure (2011) (22)
HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells (2009) (22)
Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury. (2018) (21)
Characterization of a cis-acting element required for efficient transcriptional activation of the collagen IV enhancer. (1991) (21)
Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats. (1985) (21)
The Effects of Minoxidil on Pulmonary and Systemic Hemodynamics in Hypertensive Man (1977) (21)
Influence of Prothymosin‐α on HIV‐1 Target Cells (2007) (19)
A novel sequence in the type IV collagen promoter binds nuclear proteins from Engelbreth-Holm-Swarm tumor. (1992) (19)
Renal TGF-beta in HIV-associated kidney diseases. (1997) (19)
The pathogenesis of HIV-associated nephropathy. (2010) (18)
Adult and fetal human mesangial cells interact with specific laminin domains. (1991) (17)
Fact and Fiction: Debunking Myths in the US Healthcare System (2008) (17)
Cardiac Dysfunction in HIV‐1 Transgenic Mouse: Role of Stress and BAG3 (2015) (17)
HIV-associated nephropathy. (2008) (17)
Nuclear factor-κB binding to the HIV-1 LTR in kidney: Implications for HIV-associated nephropathy (2001) (17)
Bilateral native nephrectomy improves renal isograft function in rats. (1986) (17)
Dual tropism of HIV-1 envelopes derived from renal tubular epithelial cells of patients with HIV-associated nephropathy (2006) (17)
The patient-centered medical home and nephrology. (2009) (17)
Nephropathy in HIV-transgenic mice. (1994) (16)
Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog. (1987) (16)
Inhibition of HIV-1 expression by HIV-2 (1995) (16)
Influence of prothymosin-alpha on HIV-1 target cells. (2007) (16)
Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient. (2020) (16)
Increased oxidative metabolism in renal tubules from spontaneously hypertensive rats. (1989) (16)
Professing and living the oath: teaching medicine as a profession. (2002) (15)
Extracellular matrix gene expression in experimental glomerulonephritis. (1993) (14)
Proteomics Analysis of the Non-Muscle Myosin Heavy Chain IIa-Enriched Actin-Myosin Complex Reveals Multiple Functions within the Podocyte (2014) (14)
Atrial natriuretic peptide-induced changes in renal prostacyclin production in ureteral obstruction. (1990) (14)
Effect of target cell availability on HIV-1 production in vitro (2002) (13)
Mitochondrial dysfunction in human immunodeficiency virus‐1 transgenic mouse cardiac myocytes (2018) (13)
12-O-tetradecanoylphorbol 13-acetate stimulates human T-lymphocyte adherence to the fibronectin RGD domain and the laminin IKVAV domain. (1994) (13)
Glomerular MYH9 expression is reduced by HIV-1 (2012) (13)
HIV Type-1 Transgene Expression in Mice Alters Adipose Tissue and Adipokine Levels: Towards a Rodent Model of HIV Type-1 Lipodystrophy (2010) (13)
Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice. (1998) (12)
Transgenic animal models of renal development and pathogenesis. (1995) (12)
A PCR method for the quantitative assessment of mRNA for laminin A, B1, and B2 chains. (1992) (12)
Post-transplant hypertension in the rat: effects of captopril and native nephrectomy. (1989) (12)
Role of SIRT1 in HIV-associated kidney disease. (2020) (11)
Adeno-Associated Virus Gene Transfer into Renal Cells: Potential for in vivo Gene Delivery (1998) (11)
HIV-1 transgenic expression in mice induces selective atrophy of fast-glycolytic skeletal muscle fibers. (2008) (11)
Efavirenz: innocent bystander or direct nephrotoxin? (2007) (11)
Expression of transforming growth factor beta 3 in hypertrophic juxtaglomerular apparatus. (1994) (11)
Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. (1993) (11)
Maternal-Fetal Interactions Affect Growth of Human Immunodeficiency Virus Type 1 Transgenic Mice (1995) (11)
Nuclear factor-kappa B binding to the HIV-1 LTR in kidney: implications for HIV-associated nephropathy. (2001) (10)
Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts. (1989) (10)
World Kidney Day 2011. (2011) (9)
Bradykinin stimulation of oxidative metabolism in renal cortical tubules from rabbit. Possible role of arachidonic acid. (1985) (9)
Renovascular hypertension in blacks. (1996) (9)
Double-blind comparison of doxazosin, nadolol, and placebo in patients with mild-to-moderate hypertension (1988) (8)
Modulation of renin release and renal vascular smooth muscle cell contractility by TGF-beta 2. (1996) (7)
High-protein feeding stimulates renal thromboxane production in rats with streptozocin-induced diabetes. (1989) (7)
Renal vascular induction of TGF-beta 2 and renin by potassium depletion. (1993) (7)
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. (1987) (6)
Calcium regulation of a cell surface nucleic acid channel. (1996) (6)
HIV-associated nephropathy: a case study in race and genetics. (2006) (6)
Optimizing Ribozymes for Somatic Cell Gene Therapy (1998) (6)
Presence of the nucleic acid channel in renal brush-border membranes: allosteric modulation by extracellular calcium. (2005) (6)
EFFECT OF DIETARY FISH OIL SUPPLEMENTATION ON EICOSANOID PRODUCTION BY RAT RENAL ALLOGRAFTS (1988) (6)
Localization of the Nucleic Acid Channel Regulatory Subunit, Cytosolic Malate Dehydrogenase (2008) (6)
Renal effects of aprotinin after 24 hours of unilateral ureteral obstruction. (1987) (5)
Renal allograft function, arachidonic acid metabolism, and systemic cellular immunity after kidney transplantation in the rat (1987) (4)
Unsung Hero Robert C. Gallo (2009) (4)
HIV-1 dynamics in haemodialysis patients. (2002) (4)
Faculty of 1000 evaluation for Outcomes of kidney transplantation in HIV-infected recipients. (2011) (4)
Early treatment with ACE inhibition may benefit HIV-associated nephropathy patients. (1998) (4)
Editorial comment: renal insufficiency in HIV-infected patients may not always be HIVAN. (2002) (4)
Regulation of basement membrane genes. (1990) (4)
Kidney disease in HIV infection: introduction. (2008) (3)
Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans (2021) (3)
CHAPTER 28 – Renal Complications of HIV Infection (2008) (3)
The future of malpractice reform. (2010) (3)
Polarity of alpha-galactosidase A uptake by renal tubule cells. (2002) (3)
Polarity of α-galactosidase A uptake by renal tubule cells (2002) (3)
Physiology and cell biology update: mechanisms of type IV collagen gene regulation. (1991) (2)
Associations between rat renal allograft function, inflammation, and host immunity. (1987) (2)
Regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity in the mouse after uninephrectomy. (1989) (2)
Induction of transforming growth factor-beta 2-3 in the juxtaglomerular apparatus and renal vascular smooth muscle cells of young rats and infants. (1994) (2)
Follow the leader. (2011) (2)
The renin-angiotensin system as a mediator of renal injury in hypertension. (1998) (2)
Essentials of Hospital Medicine:A Practical Guide for Clinicians (2012) (2)
Reference plasmid pHXB2_D is an HIV-1 molecular clone that exhibits identical LTRs and a single integration site indicative of an HIV provirus (2019) (2)
P1758The novel small leucin-rich repeat protein podocan is an independent predictor of major adverse cardiac events in patients with angiographically-defined coronary artery disease (2019) (1)
Abstract 16488: Overexpression of the Human Form of the Novel Extracellular Matrix Protein Podocan Inhibits Migration and Proliferation of Human Vascular Smooth Muscle Cells via Down-Regulation of the Wnt-Pathway (2011) (1)
Comparison of Intravenous Digital Subtraction Angiography and Conventional Arteriography in Defining Renal Anatomy (1988) (1)
Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro. (2004) (1)
AIDS and the kidney. Introduction. (1998) (1)
Nef as a Proliferative Factor for Kidney Epithelial Cells in HIV-Associated Nephropathy (2008) (1)
Tubular-specific expression of HIV protein Vpr leads to severe tubulointerstitial damage accompanied by progressive fibrosis and cystic development. (2022) (1)
Abstract 17034: The Novel Extracellular Matrix Protein Podocan Shows a Distinct Expression Pattern in Human Primary versus Restenotic Atherosclerotic Coronary Lesions and its Lack of Extra-Cellular Expression in Restenotic Tissue is Associated with Increased Wnt-Pathway Activation (2011) (1)
Gene therapy and renal disease. Introduction. (2002) (1)
426 Datathon Revisited: Implementation of Lesson Learned (2023) (0)
Lessons learned from an enterprise-wide clinical datathon (2022) (0)
Disease of the Month Highly Active Antiretroviral Therapy and the Epidemic of HIV ! End-Stage Renal Disease (2008) (0)
8.8-03 Donor specific transfusion (DST) does not normalize long term function or inflammatory mediator production by rat renal allografts (1989) (0)
Faculty Opinions recommendation of Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. (2013) (0)
DKK1 PREDICTS VASCULAR CALCIFICATION AND CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION (2019) (0)
ROLE OF WINGLESS-REGULATORY MOLECULES DICKKOPF-RELATED PROTEIN 1 AND PODOCAN ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH AORTIC STENOSIS (2019) (0)
The Early Years : AIDS and AIDS Nephropathy in the Early 1980 s (2007) (0)
Differential Distribution of Podocan Isoforms (2009) (0)
Abstract 17353: Comparing the Association of DKK-1, a Wingless (Wnt)-Regulatory Molecule, and CRP-1 With Cardiovascular Risk Factor Profile and Coronary Plaque Burden in Patients With Coronary Artery Disease (2018) (0)
Kidney Disorders in Human Immunodeficiency Virus Infection (2009) (0)
Chapter 24 – Renal Manifestations of HIV Infection (2003) (0)
extracellular calcium brush-border membranes : allosteric modulation by Presence of the nucleic acid channel in renal (2005) (0)
HIV transgenic mouse model for disseminated cryptococcosis (1996) (0)
Chapter 24 – Hepatitis B- and HIV-Related Renal Diseases (2008) (0)
COMPARING CARDIOVASCULAR (CV) OUTCOMES IN CANCER SURVIVORS WITH CORONARY ARTERY DISEASE (CAD) VERSUS CAD PATIENTS WITHOUT CANCER HISTORY: ROLE OF WNT PATHWAY AND INFLAMMATION (2019) (0)
Sustained-release trimazosin in the treatment of mild-to-moderate hypertension (1986) (0)
Abstract 1453: Evidence for Increased Neointima Formation in Podocan Knockout Mice compared to C57/BL6 Wild Type Mice After Arterial Denudating Injury (2006) (0)
Chapter 23 – Renal complications of HIV infection (2012) (0)
Chapter 23 – Pathogenesis of HIV-Associated Nephropathy (2008) (0)
Faculty Opinions recommendation of Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients. (2014) (0)
Technical Seminar: Strategies for Functional Inactivation of Genes (1998) (0)
Where There Are Challenges, There Is Huge Opportunity: Dr. Paul Klotman, Baylor College of Medicine Commencmenet (2015) (0)
mild hypertension Double-blind, placebo-controlled trial of potassium chloride in the treatment of (2011) (0)
Renal Disease and HIV (2007) (0)
PODOCAN IS INVERSELY RELATED TO WINGLESS SIGNALING PATHWAY MOLECULES DICKKOPF-RELATED PROTEIN 1 IN RELATION TO AORTIC DIAMETERS IN PATIENTS WITH BICUSPID AORTIC VALVE (2019) (0)
Abstract 431: The Novel Small Leucin Rich Repeat Protein Podocan Regulates Smooth Muscle Cell Function via the Wnt Pathway (2008) (0)
COMPARISON OF INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND CONVETIONAL ARTERIOGRAPHY IN DEFINING RENAL ANATOMY1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL (1988) (0)
HIV-1 Infection of Human T Lymphocytes Results in Enhanced a s 01 Integrin Expression (2002) (0)
Characterization of the Collagen IV Enhancer (1990) (0)
Faculty Opinions recommendation of Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. (2012) (0)
HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein (DIP) (2008) (0)

This paper list is powered by the following services:

Other Resources About Paul Klotman

en.wikipedia.org

What Schools Are Affiliated With Paul Klotman?

Paul Klotman is affiliated with the following schools: